Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells $20,839.20 in Stock

Phreesia, Inc. (NYSE:PHR) insider Janet Gunzburg sold 912 shares of Phreesia stock in a transaction that occurred on Thursday, April 18th. The shares were sold at an average price of $22.85, for a total value of $20,839.20. Following the completion of the sale, the insider now owns 35,220 shares in the company, valued at $804,777. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Janet Gunzburg also recently made the following trade(s):

• On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The stock was sold at an average price of $23.10, for a total value of $63,940.80.
• On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total value of $38,657.58.
• On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
• On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The stock was sold at an average price of $28.00, for a total value of $13,440.00.
• On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The stock was sold at an average price of $25.99, for a total value of $8,524.72.

Phreesia Stock Performance

Phreesia stock opened at $21.70 on Monday. The firm has a market capitalization of $1.22 billion, a P/E ratio of -8.61 and a beta of 0.92. The stock has a fifty day moving average price of $24.28 and a 200 day moving average price of $21.33. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $34.98. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. During the same quarter in the previous year, the business earned ($0.72) earnings per share. The firm’s quarterly revenue was up 24.0% compared to the same quarter last year. Equities research analysts anticipate that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently added to or reduced their stakes in PHR. Brown Advisory Inc. grew its position in Phreesia by 22.2% during the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after acquiring an additional 716,374 shares during the period. FMR LLC grew its position in Phreesia by 8.6% during the third quarter. FMR LLC now owns 7,856,551 shares of the company’s stock valued at $146,760,000 after acquiring an additional 624,456 shares during the period. Rock Springs Capital Management LP grew its position in Phreesia by 36.1% during the third quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock valued at $33,183,000 after acquiring an additional 471,391 shares during the period. Norges Bank purchased a new stake in shares of Phreesia in the fourth quarter worth about $8,199,000. Finally, BlackRock Inc. boosted its position in shares of Phreesia by 5.8% in the first quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock worth $167,640,000 after buying an additional 349,301 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

PHR has been the subject of several research reports. Barclays assumed coverage on Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective for the company. Truist Financial assumed coverage on Phreesia in a report on Monday, February 26th. They issued a “buy” rating and a $35.00 price target for the company. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, March 15th. Robert W. Baird boosted their price target on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Finally, Canaccord Genuity Group boosted their price target on Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.